Articles

Podcasts

Videos

Clinical

Similar to HIV, the colonial and postcolonial history is fundamental to the biology of this monkeypox outbreak.

A Viral Colonial Legacy: HIV, Monkeypox Emerged Due to Ongoing Colonial Viral Neglect

The AIDS Clinical Trials Group (ACTG) is launching a phase 3 trial to evaluate the safety and efficacy of tecovirimat to treat monkeypox in vulnerable populations.

Trial Launching to Study Tecovirimat as Monkeypox Treatment 

Investigators surmise a natural bat exposure within certain areas of the world may correspond with lower COVID-19 incidence rates.

Can Zoonotic Exposure Predict COVID-19 Prevalence?

A Study of HIV and STIs Among People With Monkeypox

2 Washington, DC monkeypox patients presented with lesions and proctitis, and were treated with oral tecovirimat.

Oral Tecovirimat for Monkeypox Proctitis: 2 Case Studies

Ongoing wastewater surveillance in San Diego seeks to track and predict monkeypox infection surges.

Can Wastewater Surveillance Predict Monkeypox Cases?

Next generation antimalarial monoclonal antibody is three times more potent than predecessor in preventing parasitemia, stopping parasite replicating.

Next Generation Antimalarial MAB Targets Susceptibility of P falciparum

Langya virus, a new type of henipavirus, was identified in at least 35 people in eastern China. The virus is suspected to have infected shrews before jumping to humans.

Langya Virus Zoonotic Spillover in Eastern China

The agency decided to allow for intradermal injection thus increasing the number of available doses substantially. 

In Hopes of Stretching Supplies, FDA Changes How Monkeypox Vaccines are Administered

The federal agency and international organization offer some insights on patient epidemiology, and the high-risk groups that public health officials and clinicians should consider for vaccines and education efforts.

ZOONOTIC & VECTOR-BORNE DISEASES

Latest News